182 related articles for article (PubMed ID: 25227424)
1. Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC.
Gaber R; Watermann I; Kugler C; Reinmuth N; Huber RM; Schnabel PA; Vollmer E; Reck M; Goldmann T
Diagn Pathol; 2014 Sep; 9():165. PubMed ID: 25227424
[TBL] [Abstract][Full Text] [Related]
2. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
Lee HJ; Xu X; Choe G; Chung DH; Seo JW; Lee JH; Lee CT; Jheon S; Sung SW; Chung JH
Lung Cancer; 2010 Jun; 68(3):375-82. PubMed ID: 19712993
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
Dziadziuszko R; Merrick DT; Witta SE; Mendoza AD; Szostakiewicz B; Szymanowska A; Rzyman W; Dziadziuszko K; Jassem J; Bunn PA; Varella-Garcia M; Hirsch FR
J Clin Oncol; 2010 May; 28(13):2174-80. PubMed ID: 20351332
[TBL] [Abstract][Full Text] [Related]
4. EGFR-immunohistochemistry in colorectal cancer and non-small cell lung cancer: comparison of 3 commercially available EGFR-antibodies.
Buffet W; Geboes KP; Dehertogh G; Geboes K
Acta Gastroenterol Belg; 2008; 71(2):213-8. PubMed ID: 18720932
[TBL] [Abstract][Full Text] [Related]
5. Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer.
Zhang Y; Yang H; Qiu Y; Deng Q; Liu J; Zhao M; He P; Mo M; Zou X; He J
Med Oncol; 2014 Mar; 31(3):803. PubMed ID: 24452282
[TBL] [Abstract][Full Text] [Related]
6. Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer.
Salido M; Pijuan L; Martínez-Avilés L; Galván AB; Cañadas I; Rovira A; Zanui M; Martínez A; Longarón R; Sole F; Serrano S; Bellosillo B; Wynes MW; Albanell J; Hirsch FR; Arriola E
J Thorac Oncol; 2011 Jan; 6(1):21-7. PubMed ID: 21107285
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.
Pinter F; Papay J; Almasi A; Sapi Z; Szabo E; Kanya M; Tamasi A; Jori B; Varkondi E; Moldvay J; Szondy K; Keri G; Dominici M; Conte P; Eckhardt S; Kopper L; Schwab R; Petak I
J Mol Diagn; 2008 Mar; 10(2):160-8. PubMed ID: 18258923
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
Bhargava R; Chen B; Klimstra DS; Saltz LB; Hedvat C; Tang LH; Gerald W; Teruya-Feldstein J; Paty PB; Qin J; Shia J
Cancer; 2006 Apr; 106(8):1857-62. PubMed ID: 16532444
[TBL] [Abstract][Full Text] [Related]
9. Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer.
Simone G; Mangia A; Malfettone A; Rubini V; Siciliano M; Di Benedetto A; Terrenato I; Novelli F; Mottolese M
J Exp Clin Cancer Res; 2010 Sep; 29(1):125. PubMed ID: 20843314
[TBL] [Abstract][Full Text] [Related]
10. Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients.
Ludovini V; Flacco A; Bianconi F; Ragusa M; Vannucci J; Bellezza G; Chiari R; Minotti V; Pistola L; Tofanetti FR; Siggillino A; Baldelli E; Sidoni A; Daddi N; Puma F; Varella-Garcia M; Crinò L
Cancer Chemother Pharmacol; 2013 Mar; 71(3):671-80. PubMed ID: 23314677
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer.
Hirsch FR; Dziadziuszko R; Thatcher N; Mann H; Watkins C; Parums DV; Speake G; Holloway B; Bunn PA; Franklin WA
Cancer; 2008 Mar; 112(5):1114-21. PubMed ID: 18219661
[TBL] [Abstract][Full Text] [Related]
12. EGFR expression as an ancillary tool for diagnosing lung cancer in cytology specimens.
Wei EX; Anga AA; Martin SS; Jackson JG; Nordberg ML; Herrera GA; Turbat-Herrera EA
Mod Pathol; 2007 Sep; 20(9):905-13. PubMed ID: 17643093
[TBL] [Abstract][Full Text] [Related]
13. Preselection of EGFR mutations in non-small-cell lung cancer patients by immunohistochemistry: comparison with DNA-sequencing, EGFR wild-type expression, gene copy number gain and clinicopathological data.
Gaber R; Watermann I; Kugler C; Vollmer E; Perner S; Reck M; Goldmann T
Rom J Morphol Embryol; 2017; 58(4):1175-1184. PubMed ID: 29556606
[TBL] [Abstract][Full Text] [Related]
14. EGFR expression and gene copy number in triple-negative breast carcinoma.
Gumuskaya B; Alper M; Hucumenoglu S; Altundag K; Uner A; Guler G
Cancer Genet Cytogenet; 2010 Dec; 203(2):222-9. PubMed ID: 21156237
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer.
Jeon YK; Sung SW; Chung JH; Park WS; Seo JW; Kim CW; Chung DH
Lung Cancer; 2006 Dec; 54(3):387-98. PubMed ID: 17011067
[TBL] [Abstract][Full Text] [Related]
16. Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations.
Kato Y; Peled N; Wynes MW; Yoshida K; Pardo M; Mascaux C; Ohira T; Tsuboi M; Matsubayashi J; Nagao T; Ikeda N; Hirsch FR
J Thorac Oncol; 2010 Oct; 5(10):1551-8. PubMed ID: 20697298
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers.
Savic S; Tapia C; Grilli B; Rufle A; Bihl MP; de Vito Barascud A; Herzog M; Terracciano L; Baty F; Bubendorf L
Br J Cancer; 2008 Jan; 98(1):154-60. PubMed ID: 18087280
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies.
Xiong Y; Bai Y; Leong N; Laughlin TS; Rothberg PG; Xu H; Nong L; Zhao J; Dong Y; Li T
Diagn Pathol; 2013 Feb; 8():27. PubMed ID: 23419122
[TBL] [Abstract][Full Text] [Related]
19. Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas.
Liang Z; Zhang J; Zeng X; Gao J; Wu S; Liu T
BMC Cancer; 2010 Jul; 10():376. PubMed ID: 20637128
[TBL] [Abstract][Full Text] [Related]
20. Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.
Hirsch FR; Varella-Garcia M; Cappuzzo F; McCoy J; Bemis L; Xavier AC; Dziadziuszko R; Gumerlock P; Chansky K; West H; Gazdar AF; Crino L; Gandara DR; Franklin WA; Bunn PA
Ann Oncol; 2007 Apr; 18(4):752-60. PubMed ID: 17317677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]